001431277 000__ 03356cam\a2200565\i\4500
001431277 001__ 1431277
001431277 003__ OCoLC
001431277 005__ 20230308003229.0
001431277 006__ m\\\\\o\\d\\\\\\\\
001431277 007__ cr\cn\nnnunnun
001431277 008__ 220205s2022\\\\sz\a\\\\ob\\\\000\0\eng\d
001431277 019__ $$a1296666183
001431277 020__ $$a9783030860769$$q(electronic bk.)
001431277 020__ $$a3030860760$$q(electronic bk.)
001431277 020__ $$z9783030860752
001431277 0248_ $$a10.1007/978-3-030-86076-9$$2doi
001431277 035__ $$aSP(OCoLC)1295275583
001431277 040__ $$aNLM$$beng$$erda$$epn$$cNLM$$dGW5XE$$dDKU$$dYDX$$dOCLCF$$dEBLCP$$dOCLCQ$$dYWS
001431277 042__ $$apcc
001431277 049__ $$aISEA
001431277 050_4 $$aRC692$$b.P74 2022
001431277 08204 $$a616.1/36$$223
001431277 24500 $$aPrevention and treatment of atherosclerosis :$$bimproving state-of-the-art management and search for novel targets /$$cArnold von Eckardstein, Christoph J. Binder, editors.
001431277 264_1 $$aCham :$$bSpringer,$$c[2022]
001431277 300__ $$a1 online resource :$$billustrations (chiefly color).
001431277 336__ $$atext$$btxt$$2rdacontent
001431277 337__ $$acomputer$$bc$$2rdamedia
001431277 338__ $$aonline resource$$bcr$$2rdacarrier
001431277 347__ $$atext file$$bPDF$$2rda
001431277 4901_ $$aHandbook of experimental pharmacology,$$x1865-0325 ;$$vvolume 270
001431277 504__ $$aIncludes bibliographical references.
001431277 5050_ $$aDiet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.
001431277 5060_ $$aOpen access$$5GW5XE
001431277 520__ $$aThis open access book is supported by the European Atherosclerosis Society (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. .
001431277 588__ $$aDescription based on online resource; title from HTML title page (viewed October 24, 2022).
001431277 650_0 $$aAtherosclerosis$$xPrevention.
001431277 650_0 $$aAtherosclerosis$$xTreatment.
001431277 650_6 $$aAthérosclérose$$xTraitement.
001431277 655_0 $$aElectronic books.
001431277 7001_ $$aEckardstein, Arnold von,$$eeditor.
001431277 7001_ $$aBinder, Christoph J.,$$eeditor.
001431277 7102_ $$aEuropean Atherosclerosis Society,$$esponsoring body.
001431277 77608 $$iPrint version:$$avon Eckardstein, Arnold$$tPrevention and Treatment of Atherosclerosis$$dCham : Springer International Publishing AG,c2022$$z9783030860752
001431277 830_0 $$aHandbook of experimental pharmacology ;$$vv. 270.$$x0171-2004
001431277 852__ $$bebk
001431277 85640 $$3Springer Nature$$uhttps://link.springer.com/10.1007/978-3-030-86076-9$$zOnline Access$$91397441.2
001431277 909CO $$ooai:library.usi.edu:1431277$$pGLOBAL_SET
001431277 980__ $$aBIB
001431277 980__ $$aEBOOK
001431277 982__ $$aEbook
001431277 983__ $$aOnline
001431277 994__ $$a92$$bISE